Société Tunisienne des Maladies Respiratoires et d'Allergologie STMRA - Randomized trial with nearly 30.000 individuals showed Novavax vaccine was safe and had an overall efficacy of 90.4% against symptomatic infections.

Sté Tunisienne des Maladies Respiratoires et d'Allergologie

Cercle des Bureaux - Appartement B 5-3 . 1082 Centre urbain Nord Tunis

Randomized trial with nearly 30.000 individuals showed Novavax vaccine was safe and had an overall efficacy of 90.4% against symptomatic infections.

Zouhair Souissi

Bibliographie

17 décembre 2021

Soyez le premier à commenter!

Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico – New England Journal of Medicine Commentaries: Novavax COVID vaccine shows 90.4% efficacy against infection – CIDRAP Novavax COVID-19 vaccine found to be safe and effective – University of Maryland School of Medicine Related: [Preprint] In RCT with 29,949 participants, the Novavax […]

The post Randomized trial with nearly 30.000 individuals showed Novavax vaccine was safe and had an overall efficacy of 90.4% against symptomatic infections. appeared first on Links Medicus.

Lu 588 fois